Flemming Ornskov Net Worth

Flemming Ornskov biography

Dr. Flemming Ornskov, M.D. is Independent Director of the Company. From January 8, 2019 to March 31, 2019, Dr. Ornskov served as an advisor to the CEO of Takeda Pharmaceutical Company Ltd. He served as the Chief Executive Officer Designate, as well as Board Member of Shire Plc from January 2, 2013, and as Chief Executive Officer from April 30, 2013 to January 8, 2019. From 2010 to 2012, he served as the Chief Marketing Officer and Global Head of Strategic Marketing for General & Specialty Medicine at Bayer AG. From 2008 to 2010, he served as Global President of Pharmaceuticals and OTC at Bausch & Lomb, Inc. From 2006 to 2008, he also served as the Chairman and later as President and Chief Executive Officer of Life-Cycle Pharma A/S. From 2005 to 2006, he served as President and Chief Executive Officer of Ikaria, Inc. In his pharmaceutical career, he had roles of increasing responsibility at Merck & Co. Inc. and Novartis AG.

What is the salary of Flemming Ornskov?

As the Independent Director of Waters, the total compensation of Flemming Ornskov at Waters is $318,863. There are 15 executives at Waters getting paid more, with Robert Carson having the highest compensation of $3,781,720.

How old is Flemming Ornskov?

Flemming Ornskov is 62, he's been the Independent Director of Waters since 2017. There are 5 older and 13 younger executives at Waters. The oldest executive at Waters Corp. is Michael Berendt, 70, who is the Independent Director.

What's Flemming Ornskov's mailing address?

Flemming's mailing address filed with the SEC is 34, Maple Street, Milford, Worcester County, Massachusetts, 01757, United States.

Insiders trading at Waters

Over the last 22 years, insiders at Waters have traded over $28,041,740 worth of Waters stock and bought 4,185 units worth $1,330,824 . The most active insiders traders include Joshua Bekenstein, Edward Conard, and Mark P Vergnano. On average, Waters executives and independent directors trade stock every 22 days with the average trade being worth of $5,835,071. The most recent stock trade was executed by Richard H Fearon on 28 May 2024, trading 1,000 units of WAT stock currently worth $332,900.

What does Waters do?

waters corporation (nyse: wat), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years. with approximately 7,000 employees worldwide, waters operates directly in 31 countries, including 15 manufacturing facilities, and with products available in more than 100 countries. waters corporation's businesses include waters, ta instruments, vicam, era, and nonlinear dynamics. waters creates business advantages for laboratory-dependent organizations by delivering ultra performance liquid chromatography (uplc), high-performance liquid chromatography (hplc), chromatography columns and chemistry products, mass spectrometry systems, laboratory informatics solutions, and comprehensive service programs to enable significant advancement in healthcare delivery, environmental management, food safety, and water quality. ta instruments'​ thermal analysis, rheometry

Waters executives and stock owners

Waters executives and other stock owners filed with the SEC include:

• Robert Carson,
  Senior Vice President - Corporate Development
• Ian King,
  Senior Vice President - Global Products
• Elizabeth Rae,
  Senior Vice President - Global Human Resources
• Dr. Udit Batra Ph.D.,
  Pres, CEO & Director
• Christopher O'Connell,
  Chairman of the Board
• Keeley Aleman,
  Senior Vice President, General Counsel and Corporate Secretary
• Dr. Michael C. Harrington Ph.D.,
  Consultant
• Ian S. King,
  Consultant
• Jonathan M. Pratt,
  Sr. VP of Waters Division
• Jonathan Pratt,
  Senior Vice President and President of TA Instruments
• Sherry Buck,
  Chief Financial Officer, Senior Vice President
• Michael Harrington,
  Senior Vice President - Global Markets
• JoAnn Reed,
  Independent Director
• Thomas Salice,
  Lead Independent Director
• Christopher Kuebler,
  Independent Director
• Flemming Ornskov,
  Independent Director
• Edward Conard,
  Independent Director
• Michael Berendt,
  Independent Director
• Gary Hendrickson,
  Independent Director
• Linda Baddour,
  Independent Director
• Bryan Brokmeier,
  Senior Director, Investor Relations
• Udit Batra,
  President, Chief Executive Officer, Director
• Kristen Garvey,
  VP of Corp. Communications
• Kevin Kempskie,
  Sr. Director of PR
• Keeley A. Aleman,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Caspar Tudor,
  Mang. of Investor Relations
• Daniel J. Welch,
  Sr. VP of Global Operations
• Amol Chaubal,
  Sr. VP & CFO
• Amol Chaubal,
  SVP & Chief Financial Officer
• Jianqing Bennett,
  SVP TA Instruments Division
• Daniel J. Welch,
  SVP Global Operations
• Joshua Bekenstein,
  Director
• Michael F Silveira,
  VP, Corporate Controller
• Laurie H M.D. Glimcher,
  Director
• William J Miller,
  Director
• Eugene G Cassis,
  Chief Financial Officer
• Arthur G Caputo,
  President
• Douglas A Berthiaume,
  Chairman, President and CEO
• Terrence P Kelly,
  President, TA Instruments
• David Terricciano,
  VP of Operations
• Rohit Khanna,
  Sr VP, Applied Technology
• John A Ornell,
  CFO
• Francis Kim,
  SVP Global Operations
• Robert L Iii Carpio,
  SVP, Waters Division
• William Curry,
  
• Brian K Mazar,
  Sr. VP
• Philip Caldwell,
  Director
• John R Nelson,
  EVP
• Laurie H Md Glimcher,
  Director
• Mark T Beaudouin,
  SVP and General Counsel
• Pearl S Huang,
  Director
• Belinda Hyde,
  SVP, Global Human Resources
• Wei Jiang,
  Director
• John M Ballbach,
  Director
• Mark P Vergnano,
  Director
• Daniel J. Brennan,
  Director
• Richard H Fearon,
  Director
• Heather Knight,
  Director